我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
1 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
尚未招募
100.0%
暂无批准数据
- Vizgen and Hamamatsu Photonics announced a strategic partnership integrating MoxiePlex™ multiplex immunofluorescence imaging with InSituPlex® assays for streamlined biomarker detection. - The collaboration combines 9-color imaging capabilities with high throughput capacity of up to 60 slides per run, designed for high-volume laboratory applications. - Initial deployment focuses on multiplex immunofluorescence panels for non-small cell lung cancer research, with plans to expand into broader translational pathology applications. - The integrated solution aims to eliminate common barriers in multiplex assay development while facilitating the transition from research to clinical impact.
